ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
2 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
297
|
54K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
4 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
297
|
54K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
1 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
297
|
54K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
1 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
297
|
54K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
9 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
297
|
54K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
0 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
297
|
54K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
Speckled
|
297 |
54K |
7 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
297
|
54K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
Speckled
|
18 |
5.3K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
18
|
5.3K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
Speckled
|
18 |
5.3K |
10 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
18
|
5.3K
|
10
|
|
ASX - By Stock
|
BOQ |
Re:
BOQ share price rises amid rumoured takeover interest
|
|
Speckled
|
4 |
2.4K |
7 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
4
|
2.4K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Speckled
|
28 |
10K |
16 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
28
|
10K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval to Commence Sales for Striate in Canada
|
|
Speckled
|
23 |
7.7K |
15 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
23
|
7.7K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Regulatory Approval to Commence Sales for Striate in Canada
|
|
Speckled
|
23 |
7.7K |
6 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
23
|
7.7K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
10 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
672
|
229K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Speckled
|
34 |
9.3K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.3K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Speckled
|
3.1K |
827K |
4 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
3.1K
|
827K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
7 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
672
|
229K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proposed issue of securities - OCC
|
|
Speckled
|
16 |
4.6K |
7 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
16
|
4.6K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.8K |
562K |
7 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
1.8K
|
562K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
672
|
229K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Speckled
|
91 |
30K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
91
|
30K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Part 1 Remplir US Market Authorisation Successfully Complete
|
|
Speckled
|
35 |
12K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
35
|
12K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Part 1 Remplir US Market Authorisation Successfully Complete
|
|
Speckled
|
35 |
12K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
35
|
12K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Speckled
|
20K |
7.0M |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
20K
|
7.0M
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
672
|
229K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Speckled
|
91 |
30K |
13 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
30K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Speckled
|
41 |
14K |
0 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
41
|
14K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Speckled
|
41 |
14K |
10 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
41
|
14K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
7 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
672
|
229K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Remplir Expansion Continues with Singapore Application
|
|
Speckled
|
21 |
10K |
11 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
21
|
10K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Notification of cessation of securities - OCC
|
|
Speckled
|
4 |
1.6K |
9 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
4
|
1.6K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Speckled
|
26 |
9.0K |
9 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
26
|
9.0K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.8K |
562K |
6 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.8K
|
562K
|
6
|
|
ASX - By Stock
|
BCI |
Re:
BCI Beautiful Compounding Investment
|
|
Speckled
|
1.3K |
554K |
10 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.3K
|
554K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: The Hon Kim Beazley AC Joins Orthocell Board
|
|
Speckled
|
25 |
7.6K |
14 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
25
|
7.6K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Ann: The Hon Kim Beazley AC Joins Orthocell Board
|
|
Speckled
|
25 |
7.6K |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
25
|
7.6K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: The Hon Kim Beazley AC Joins Orthocell Board
|
|
Speckled
|
25 |
7.6K |
15 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
25
|
7.6K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.8K |
562K |
12 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
1.8K
|
562K
|
12
|
|
ASX - By Stock
|
BCI |
Re:
whoah Nelly!, Ive been wrong before but......
|
|
Speckled
|
9 |
5.0K |
2 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
9
|
5.0K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.8K |
562K |
6 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.8K
|
562K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
10 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
672
|
229K
|
10
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
Speckled
|
55 |
17K |
9 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
55
|
17K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Speckled
|
1.8K |
562K |
4 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
1.8K
|
562K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Change of Director's Interest Notice-John Van Der Wielen
|
|
Speckled
|
12 |
4.6K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
12
|
4.6K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
16 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
672
|
229K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Professor Fiona Wood AM joins Orthocell Board
|
|
Speckled
|
12 |
4.2K |
15 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
12
|
4.2K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
Speckled
|
672 |
229K |
4 |
22/10/23 |
22/10/23 |
ASX - By Stock
|
672
|
229K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Speckled
|
25 |
7.5K |
9 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
25
|
7.5K
|
9
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Credit Approvals for Total Project Finance Completed
|
|
Speckled
|
28 |
9.6K |
4 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
28
|
9.6K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Annual Report to Shareholders
|
|
Speckled
|
5 |
2.8K |
5 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
5
|
2.8K
|
5
|
|